gatifloxacin has been researched along with Choroid Neovascularization in 2 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dave, SB | 2 |
| Toma, HS | 2 |
| Kim, SJ | 2 |
2 trials available for gatifloxacin and Choroid Neovascularization
| Article | Year |
|---|---|
Changes in ocular flora in eyes exposed to ophthalmic antibiotics.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bacteria; Choroidal Neovascularization; C | 2013 |
Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Choroidal Neovascularization; Conjunctiva | 2011 |